DarioHealthDRIO +1.17%62 FCF Margin % is -108.45% as of Mar. 2026. GuruFocus rates DRIO with a GF Score™ of 62/100 and a GF Value™ of $7.16 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 669 Healthcare Providers & Services companies, DarioHealth ranks worse than 92.38% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. DarioHealth's Free Cash Flow for the
three
months ended in Mar. 2026 was $-6.06 Mil. DarioHealth's Revenue for the
three
months ended in Mar. 2026 was $5.58 Mil. Therefore, DarioHealth's FCF Margin % for the quarter that ended in Mar. 2026 was -108.45%.
The historical rank and industry rank for DarioHealth's FCF Margin % or its related term are showing as below:
DRIO'
s FCF Margin % Range Over the Past 10 Years
Min: -327.76 Med: -192.12 Max: -116.66
Current: -120.03
During the past 13 years, the highest FCF Margin % of DarioHealth was -116.66%. The lowest was -327.76%. And the median was -192.12%.
DRIO's FCF Margin % is ranked worse than 92.38% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.34
vs DRIO: -120.03
DarioHealth FCF Margin % Related Terms
DarioHealth FCF Margin % Historical Data
* Premium members only.
The historical data trend for DarioHealth's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, DarioHealth's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DarioHealth FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's FCF Margin % distribution charts can be found below:
* The bar in red indicates where DarioHealth's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DarioHealth (DRIO) has a FCF Margin % of -108.45% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DarioHealth and its competitors. According to the industry distribution chart, DarioHealth ranks #618 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 92.4%.
Is DarioHealth's FCF Margin % too high?
DarioHealth's current FCF Margin % is -108.45%. Based on the distribution chart, DarioHealth ranks #618 out of 669 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, DarioHealth has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's FCF Margin % compare to BEAT and ONMD?
According to the Healthcare Providers & Services industry distribution chart, DarioHealth ranks #618 out of 669 companies for FCF Margin %. This places DarioHealth in the lower half of its industry. The industry median FCF Margin % is 3.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.34, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DarioHealth and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DarioHealth's current FCF Margin % is -108.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.16, compared to a current price of $6.06 — trading 15.4% below its estimated fair value. The current FCF Margin % is -108.45%. DarioHealth's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For DarioHealth (DRIO), the current FCF Margin % is -108.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DarioHealth (DRIO) Overvalued in 2026?
Based on GuruFocus' analysis, DarioHealth stock appears to be undervalued.
The current stock price of $6.06 is trading 15.4% below its estimated GF Value™ of $7.16.
GuruFocus considers DarioHealth to be Modestly Undervalued.
Key valuation signals for DRIO:
FCF Margin %: -108.45%
GF Value™: $7.16 vs. price of $6.06 (15.4% below fair value)
No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
62GF Score
Get the complete analysis for DRIO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRIO has been successfully added to your 
